Alembic Pharmaceuticals Limited
NSE: APLLTD BSE: APLLTD
NSE
774.05
29.55 (3.97%)
Prev Close
744.5
Open Price
743
Volume
312,295
Today Low / High
731.15 / 812.55
52 WK Low / High
731.15 / 1303.9
Range
735 - 813
BSE
776.70
32.55 (4.37%)
Prev Close
744.15
Open Price
745
Volume
8,154
Today Low / High
733.2 / 813
52 WK Low / High
725.6 / 1296.15
Range
738 - 816
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 774.05 (target range: 735 - 813), reflecting a change of 29.55 (3.96911%). On the BSE, it is listed at 776.7 (target range: 738 - 816), showing a change of 32.55 (4.37412%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
04 Mar
743.00
4.10%
03 Mar
744.15
0.05%
28 Feb
772.60
-3.75%
27 Feb
791.80
-1.98%
25 Feb
783.15
1.10%
24 Feb
803.40
-1.03%
21 Feb
812.65
-1.14%
20 Feb
802.00
1.53%
19 Feb
805.40
0.80%
18 Feb
815.30
-0.74%
17 Feb
816.45
-0.14%
14 Feb
825.00
-0.83%
13 Feb
835.90
-1.21%
12 Feb
875.35
-3.45%
11 Feb
883.80
-1.80%
10 Feb
835.00
6.35%
07 Feb
917.95
-3.41%
06 Feb
892.00
0.33%
05 Feb
880.00
0.98%
04 Feb
900.00
-2.09%
Alembic Pharmaceuticals Limited Graph
Alembic Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking Target Price for Alembic Pharmaceuticals Limited T1, T2, T3, for both Bullish or Bearish. For Bullish T1, T2, T3 and for Bearish T1, T2, T3. The stock current price is 774, with potential price targets ranging from T1, T2, T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 776.70 | 784.47 | 706.02 - 862.91 |
| 792.23 | 633.79 - 950.68 | ||
| 800.00 | 560.00 - 1,040.00 | ||
| Bearish Scenario | 776.70 | 768.93 | 692.04 - 845.83 |
| 761.17 | 608.93 - 913.40 | ||
| 753.40 | 527.38 - 979.42 |
Overview of Alembic Pharmaceuticals Limited
ISIN
INE901L01018
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
145,549
Market Cap
154,449,377,250
Last Dividend
11
Official Website
IPO Date
2011-09-20
DCF Diff
219.15
DCF
525
Financial Ratios Every Investor Needs
Stock Dividend of APLLTD
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-07-15 | July 15, 24 | 11 | 11 | 2024-07-15 | 2024-08-21 | |
| 2023-07-28 | July 28, 23 | 8 | 8 | 2023-07-28 | 2023-09-03 | |
| 2022-08-17 | August 17, 22 | 10 | 10 | 2022-08-18 | 2022-09-03 | |
| 2021-07-19 | July 19, 21 | 14 | 14 | 2021-07-20 | 2021-07-31 | |
| 2020-03-16 | March 16, 20 | 7 | 7 | 2020-03-17 | 2020-04-05 | 2020-03-06 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 6,228.63 Cr | 3,959.80 Cr | 2,268.83 Cr | 0.3643 | 438.56 Cr | 251.97 Cr | 575.81 Cr | 615.82 Cr | 31.33 | 961.67 Cr | 0.0989 |
| 2023-03-31 | 5,652.62 Cr | 1,708.82 Cr | 3,943.80 Cr | 0.6977 | 29.07 Cr | 241.05 Cr | 437.78 Cr | 341.99 Cr | 17.40 | 711.11 Cr | 0.0605 |
| 2022-03-31 | 5,231.79 Cr | 1,723.19 Cr | 3,508.60 Cr | 0.6706 | 50.59 Cr | 210.98 Cr | 587.47 Cr | 520.94 Cr | 26.50 | 924.62 Cr | 0.0996 |
| 2021-03-31 | 5,276.22 Cr | 1,521.27 Cr | 3,754.95 Cr | 0.7117 | 25.38 Cr | 208.66 Cr | 1,296.84 Cr | 1,146.50 Cr | 59.18 | 1,567.57 Cr | 0.2173 |
| 2020-03-31 | 4,491.97 Cr | 1,314.11 Cr | 3,177.86 Cr | 0.7075 | 42.64 Cr | 155.12 Cr | 1,111.41 Cr | 828.82 Cr | 43.97 | 1,184.30 Cr | 0.1845 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 120.21 Cr | 6,445.58 Cr | 1,627.38 Cr | 4,818.2000 Cr | 513.16 Cr | 392.95 Cr | 1,643.54 Cr | 3,071.05 Cr | 0.00 Cr | 0.00 Cr | 93.02 Cr | 1,455.0000 Cr |
| 2023-03-31 | 75.48 Cr | 6,182.83 Cr | 1,812.36 Cr | 4,370.4700 Cr | 722.02 Cr | 646.54 Cr | 1,475.27 Cr | 2,999.73 Cr | 218.79 Cr | -83.14 Cr | 96.33 Cr | 1,636.9300 Cr |
| 2022-03-31 | 61.09 Cr | 7,122.03 Cr | 1,884.48 Cr | 5,237.5500 Cr | 717.11 Cr | 656.02 Cr | 1,609.70 Cr | 3,947.26 Cr | 365.18 Cr | -197.69 Cr | 118.40 Cr | 1,716.5300 Cr |
| 2021-03-31 | 98.06 Cr | 6,708.98 Cr | 1,642.01 Cr | 5,127.6100 Cr | 583.61 Cr | 485.55 Cr | 1,486.15 Cr | 3,648.03 Cr | 299.87 Cr | 85.52 Cr | 49.31 Cr | 1,280.8400 Cr |
| 2020-03-31 | 71.84 Cr | 5,989.05 Cr | 2,798.60 Cr | 3,219.4100 Cr | 1,830.69 Cr | 1,758.85 Cr | 1,187.53 Cr | 3,099.01 Cr | 213.38 Cr | 74.51 Cr | 17.62 Cr | 1,751.6000 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 803.2000 Cr | -320.6100 Cr | -437.8700 Cr | 475.7300 Cr | 44.7300 Cr | 120.2100 Cr | -327.4700 Cr | 615.8200 Cr | -205.4100 Cr | -157.2500 Cr | -168.2800 Cr |
| 2023-03-31 | 723.9500 Cr | -447.5900 Cr | -261.9600 Cr | 280.5400 Cr | 14.3900 Cr | 75.4800 Cr | -443.4100 Cr | 354.5900 Cr | 5.8700 Cr | -196.5600 Cr | 134.4400 Cr |
| 2022-03-31 | 552.3500 Cr | -371.9700 Cr | -217.3500 Cr | 126.7100 Cr | -36.9700 Cr | 61.0900 Cr | -425.6400 Cr | 620.1100 Cr | 129.9800 Cr | -275.1900 Cr | -123.5500 Cr |
| 2021-03-31 | 1,463.3800 Cr | -838.8100 Cr | -597.4300 Cr | 803.8700 Cr | 26.2200 Cr | 98.0600 Cr | -659.5100 Cr | 1,368.0800 Cr | -397.9900 Cr | 0.0000 Cr | -298.6200 Cr |
| 2020-03-31 | 449.1300 Cr | -731.6300 Cr | 154.8500 Cr | -285.7700 Cr | -127.2300 Cr | 71.8400 Cr | -734.9000 Cr | 999.8200 Cr | 160.5300 Cr | -325.9700 Cr | -220.2700 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,692.74 Cr | 439.54 Cr | 1,253.20 Cr | 0.7403 | 0.00 Cr | 138.42 Cr | 7.01 | 270.08 Cr | 0.0818 |
| 2024-09-30 | 1,647.98 Cr | 429.12 Cr | 1,218.86 Cr | 0.7396 | 168.75 Cr | 153.41 Cr | 7.79 | 269.74 Cr | 0.0931 |
| 2024-06-30 | 1,561.73 Cr | 842.90 Cr | 718.83 Cr | 0.4603 | 167.79 Cr | 134.71 Cr | 6.84 | 238.93 Cr | 0.0863 |
| 2024-03-31 | 1,516.98 Cr | 850.70 Cr | 666.28 Cr | 0.4392 | 190.58 Cr | 178.21 Cr | 9.07 | 263.66 Cr | 0.1175 |
| 2023-12-31 | 1,630.57 Cr | 460.76 Cr | 1,169.81 Cr | 0.7174 | 199.75 Cr | 180.45 Cr | 9.18 | 269.26 Cr | 0.1107 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 122.05 Cr | 27.22 Cr | 149.27 Cr | 0.00 Cr | 2,012.52 Cr | 3,762.39 Cr | 3,124.86 Cr | 7,230.25 Cr | 2,342.61 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 120.21 Cr | 0.00 Cr | 0.00 Cr | 120.21 Cr | 0.00 Cr | 0.00 Cr | -4,818.20 Cr |
| 2024-03-31 | 126.57 Cr | 27.13 Cr | 126.57 Cr | 1,024.84 Cr | 1,643.54 Cr | 3,078.56 Cr | 3,071.07 Cr | 6,445.58 Cr | 1,627.38 Cr |
| 2023-12-31 | -147.80 Cr | 295.60 Cr | 147.80 Cr | 0.00 Cr | 0.00 Cr | 147.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 141.30 Cr | 17.22 Cr | 158.52 Cr | 1,075.07 Cr | 1,539.24 Cr | 3,134.13 Cr | 3,080.82 Cr | 6,455.27 Cr | 1,985.26 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 134.71 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 178.21 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 180.45 Cr | 138.90 Cr | 0.00 Cr | 0.00 Cr | 138.90 Cr | 286.70 Cr | 147.80 Cr | 0.00 Cr | 138.90 Cr |
| 2023-09-30 | 136.56 Cr | 135.12 Cr | 0.00 Cr | 0.00 Cr | 135.12 Cr | 147.80 Cr | 12.68 Cr | 0.00 Cr | 135.12 Cr |
| 2023-06-30 | 120.60 Cr | 132.36 Cr | 0.00 Cr | 0.00 Cr | 132.36 Cr | 214.63 Cr | 82.27 Cr | 0.00 Cr | 132.36 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,558.65 | ₹3,739,637,772,000.00 | ₹781,719.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,506.25 | ₹1,461,738,681,250.00 | ₹64,908.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹2,949.60 | ₹998,277,372,000.00 | ₹166,276.00 |
| Mankind Pharma Limited | MANKIND | ₹2,291.25 | ₹945,320,533,950.00 | ₹177,711.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,114.75 | ₹928,700,476,795.00 | ₹434,095.00 |
| Lupin Limited | LUPIN | ₹1,934.60 | ₹883,108,142,600.00 | ₹259,741.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹870.20 | ₹875,621,346,000.00 | ₹343,556.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,050.85 | ₹610,335,781,700.00 | ₹413,280.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,591.20 | ₹548,946,828,000.00 | ₹17,608.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,313.55 | ₹370,668,047,400.00 | ₹97,865.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,339.40 | ₹339,811,137,600.00 | ₹56,310.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,451.70 | ₹306,246,750,400.00 | ₹61,223.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,161.90 | ₹295,779,073,500.00 | ₹165,600.00 |
| Laurus Labs Limited | LAURUSLABS | ₹541.60 | ₹292,059,424,800.00 | ₹1,255,902.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,614.85 | ₹251,280,349,100.00 | ₹29,467.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,238.20 | ₹201,165,401,200.00 | ₹280,998.00 |
| Piramal Enterprises Limited | PEL | ₹877.00 | ₹197,744,206,000.00 | ₹172,994.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹7,180.00 | ₹179,500,000,000.00 | ₹18,235.00 |
| Eris Lifesciences Limited | ERIS | ₹1,181.00 | ₹160,768,349,000.00 | ₹22,410.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹775.65 | ₹152,464,090,950.00 | ₹312,147.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹917.85 | ₹146,196,065,850.00 | ₹70,165.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹11,307.10 | ₹145,068,962,290.00 | ₹40,103.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹801.90 | ₹143,628,309,000.00 | ₹553,341.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,794.05 | ₹136,368,790,385.00 | ₹351,707.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹474.45 | ₹115,051,278,300.00 | ₹761,172.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,120.00 | ₹84,988,928,000.00 | ₹2,119.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹733.60 | ₹66,483,240,936.00 | ₹180,483.00 |
| FDC Limited | FDC | ₹380.40 | ₹61,932,924,000.00 | ₹76,550.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹623.30 | ₹60,953,067,970.00 | ₹158,952.00 |
| Strides Pharma Science Limited | STAR | ₹606.80 | ₹55,924,326,360.00 | ₹175,466.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹912.85 | ₹46,298,930,435.00 | ₹61,199.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹630.35 | ₹44,380,296,030.00 | ₹15,929.00 |
| Hikal Limited | HIKAL | ₹353.10 | ₹43,537,583,100.00 | ₹104,019.00 |
| Innova Captab Limited | INNOVACAP | ₹676.60 | ₹38,718,387,638.00 | ₹65,536.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹117.03 | ₹37,978,809,660.00 | ₹840,880.00 |
| Sequent Scientific Limited | SEQUENT | ₹145.38 | ₹36,388,904,760.00 | ₹484,563.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,080.00 | ₹34,401,120,000.00 | ₹13,355.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹316.20 | ₹31,707,903,600.00 | ₹60,257.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹346.80 | ₹31,652,436,000.00 | ₹50,219.00 |
| Suven Life Sciences Limited | SUVEN | ₹116.15 | ₹25,329,295,100.00 | ₹387,876.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹45.64 | ₹25,008,620,560.00 | ₹2,413,022.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹469.75 | ₹23,648,166,244.00 | ₹100,544.00 |
| Alembic Limited | ALEMBICLTD | ₹89.77 | ₹23,051,320,050.00 | ₹318,318.00 |
| Indoco Remedies Limited | INDOCO | ₹226.93 | ₹20,933,815,947.00 | ₹228,598.00 |
| Bajaj HealthCare Limited | BAJAJHCARE | ₹635.05 | ₹20,056,974,665.00 | ₹289,638.00 |
Key Executives
MD & Executive Director
Mr. Shaunak Chirayu Amin
Gender: male
Year Born: 1978
Chief Business Development Officer
Mr. Udit C. Amin
Gender: male
Year Born: 1980
Company Secretary & Compliance Officer
Ms. Manisha Saraf
Gender: female
Year Born:
Chief Scientific Officer
Dr. J. Venkat Raman M. S., Ph.D.
Gender: Not Specified
Year Born: 1958
Managing Director
Mr. Pranav Chirayu Amin
Gender: male
Year Born: 1975
Director of Finance, Chief Financial Officer & Executive Director
Mr. Raj Kumar Shreeram Baheti B.Com.(Hon.), FCA, FCS
Gender: male
Year Born: 1959
Senior Vice President
Mr. Gautam Chatterjee
Gender: male
Year Born: 1961
Senior Vice President of Finance
Mr. Ajay Kumar Desai
Gender: male
Year Born:
Head of Technical Operations
Mr. Sudhakar Pandiyan
Gender: male
Year Born:
Executive Chairman & Chief Executive Officer
Mr. Chirayu Ramanbhai Amin
Gender: male
Year Born: 1946
FAQs about Alembic Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Mr. Chirayu Ramanbhai Amin.
What is the current market price of the stock?
The current price is ₹785.75.
What is the 52-week price range?
The range is ₹731.15-1303.9.
What is the market capitalization of the company?
The market capitalization is ₹15,444.94 crores.
What is the dividend yield?
The dividend yield is 1.40%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 25.66.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Alembic Pharmaceuticals Limited (ISIN: INE901L01018) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹15,444.94 crores and an average daily volume of 145,549 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹11.